The paradox of the renin-angiotensin system in chronic renal disease

Kidney International

Volumn 45, Issue 2, 1994, Pages 403-410

  Rosenberg, Mark E ^a   Smith, Lawrence J ^a   Correa Rotter, Ricardo ^a   Hostetter, Thomas H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0028157391     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1994.52     Document Type: Conference Paper

References (102)

1. HOSTETTER TH, OLSON JL, RENNKE HG, VENKATACHALAM MA, BRENNER BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
2. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BW: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
3. ANDERSON S, RENNKE H, BRENNER B: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
4. EDWARDS RM: Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 244:F526-F534, 1983
5. YUAN BH, ROBINETTE JB, CONGER JD: Effect of angiotensin II and norepinephrine on isolated rat afferent arterioles. Am J Physiol 258:F741-F750, 1990
6. PELAYO JC, QUAN AH, SHANLEY PF: Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am J Physiol 258:F414-F422, 1990
7. MEYER TW, ANDERSON S, RENNKE HG, BRENNER BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31:752-759, 1987
8. HOSTETTER TH, TROY JL, BRENNER BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
9. ZATZ R, DUNN BR, MEYER TW, ANDERSON B, RENNKE HG, BRENNER BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
10. ANDERSON S, RENNKE HG, GARCIA DZ, BRENNER BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
11. ANDERSON S, DIAMOND JR, KARNOVSKY MJ, BRENNER BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82:1757-1768, 1988
12. DIAMOND JR, ANDERSON S: Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Am J Pathol 137:1323-1332, 1990
13. TIMMERMANS V, PEAKE PW, CHARLESWORTH JA, MACDONALD GJ, PAWLAK MA: Angiotensin II receptor regulation in antiglomerular basement membrane nephritis. Kidney Int 38:518-524, 1990
14. DWORKIN LD, GROSSER M, FEINER H, ULLIAN M, PARKER M: Renal vascular effects of antihypertensive therapy in uninephrectomy SHR. Kidney Int 35:790-798, 1989
15. REMUZZI A, PUNTORIERI S, BATTAGLIA C, BERTANI T, REMUZZI G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lesser glomerular injury in the rat. J Clin Invest 85:541-549, 1990
16. KEANE WF, ANDERSON S, AURELL M, DE ZEEUW D, NARINS RG, POVAR G: Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Int Med 111:503-516, 1989
17. LINDEMAN RD, TOBIN JD, SHOCK NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861-868, 1984
18. HERLITZ H, EDENO C, MULEC H, WESTBERG G, AURELL M: Captopril treatment of hypertension and renal failure in systemic lupus erythematosis. Nephron 38:253-256, 1984
19. TAGUMA Y, KITAMOTO Y, FUTAKI G, UEDA H, MONMA H, ISHIZAKI M, TAKAHASHI H, SEKINO H, SASAKI Y: Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313:1617-1620, 1985
20. HOMMEL E, PARVING H-H, MATHIESEN E, EDSBERG B, NIELSEN MD, GIESE J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293:467-470, 1986
21. BJORCK S, NYBERG G, MULEC H, GRANERUS G, HERLITZ H, AURELL M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:471-474, 1986
22. BJORCK S, MULEC H, JOHNSEN SA, NYBERG G, AURELL M: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 300:904-907, 1990
23. INSUA A, RIBSTEIN J, MIMRAN A: Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Postgrad Med J 64(S3):59-62, 1988
24. BABA T, MURABAYASHI S, TAKEBE K: Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive (non-insulin dependent) diabetic patients with microalbuminuria: A randomized controlled trial. Diabetologia 32:40-44, 1989
25. BAKRIS GL: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Int Med 112:707-708, 1990
26. HEEG JE, DE JONG PE, VAN DER HEM GK, DE ZEEUW D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36:272-279, 1989
27. HEEG JE, DE JONG PE, VAN DER HEM GK, DE ZEEUW D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32:78-83, 1987
28. ROSENBERG ME, HOSTETTER TH: Comparative effects of antihypertensives on proteinuria: Angiotensin-converting enzyme inhibitor vs α1-antagonist. Am J Kidney Dis 16:118-125, 1990
29. RUILOPE LM, MIRANDA B, MORALES JM, RODICIO JL, ROMERO JC, RAIJ L: Converting enzyme inhibition in chronic renal failure. Am J Kid Dis 13:120, 1989
30. MANN JF, REISCH C, RITZ E: Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. Nephron 55(S1):38-42, 1990
31. DE VENUTO G, ANDREOTTI C, MATTAREI M, PEGORETTI G: Prolonged treatment of essential hypertension and renal function: Comparison of captopril and betablockers considering microproteinuria values. Curr Ther Res 38:710-718, 1985
32. MARRE M, LEBLANC H, SUAREZ L, GUYENNE T-T, MÉNARD J, PASSA P: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 294:1448-1452, 1987
33. BERGSTROM J, ALVESTRAND A, BUCHT H, GUTIERREZ A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 25:1-6, 1986
34. FALK RJ, SCHEINMAN J, PHILLIPS G, ORRINGER E, JOHNSON A, JENNETTE JC: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910-915, 1992
35. BJÖRCK S, MULEC H, JOHNSEN SA, NORDÉN G, AURELL M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-343, 1992
36. ZUCCHELLI P, ZUCCALÀ A, BORGHI M, FUSAROLI M, SASDELLI M, STALLONE C, SANNA G, GAGGI R: Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 42:452-458, 1992
37. BAUER JH, REAMS GP, HEWETT J, KLACHKO D: A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Dis 20:443-457, 1992
38. PARVING H-H, ANDERSEN AR, SMIDT UM, HOMMEL E, MATHIESEN ER, SVENDSEN PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
39. CHRISTENSEN CK, MOGENSEN CE: Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 7(SII):II-109-113, 1985
40. HACKENTHAL E, PAUL M, GANTEN D, TAUGNER R: Morphology, physiology and molecular biology of renin secretion. Pharm Rev 70:1067-1116, 1990
41. ROSENBERG ME, CORREA-ROTTER R, INAGAMI T, KREN SM, HOSTETTER TH: Glomerular renin synthesis and storage in the remnant kidney. Kidney Int 40:677-683, 1991
42. YLITALO P, HEPP R, OSTER P, MÖHRING J, GROSS F: Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats. J Lab Clin Med 88:807-816, 1976
43. YLITALO P, GROSS F: Hemodynamic changes during the development of sodium induced hypertension in subtotally nephrectomized rats. Acta Physiol Scand 106:447-455, 1979
44. DZAU VJ, BURT DW, PRATT RE: Molecular biology of the renin-angiotensin system. Am J Physiol 255:F563-F573, 1988
45. REAMS G, VILLARREAL D, BAUER JH: Intrarenal metabolism of angiotensin II. Am J Physiol 258:F1510-F1515, 1990
46. MENDELSOHN FAO: Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade. Clin Sci Lond 57:173-179, 1979
47. SEIKALY MG, ARANT BS, SENEY FD: Endogenous angiotensin concentrations in specific intrarenal compartments of the rat. J Clin Invest 86:1352-1357, 1990
48. BALLERMAN BJ, SKORECKI KL, BRENNER BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 247:F110-F116, 1984
49. WILKES BM: Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: Time course and mechanism. Endocrinology 120:1291-1298, 1987
50. HALE G, HOWARTH G, AARONS I, CLARKSON AR, WOODROFFE AJ: Quantitation of glomerular angiotensin II receptors in IgA nephropathy. Clin Nephrol 32:5-9, 1989
51. SASAKI K, YAMANO Y, BARDHAN S, IWAI N, MURRAY JJ, HASEGAWA M, MATSUDA Y, INAGAMI T: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351:230-232, 1991
52. MURPHY TJ, ALEXANDER RW, GRIENDLING KK, BERNSTEIN KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233-235, 1991
53. UNGER T, GANTEN D, LANG RE: Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications. Am J Cardiol 59:18D-22D, 1987
54. ERDOS EG, SKIDGEL RA: Renal metabolism of angiotensin I and II. Kidney Int 38:824, 1990
55. ANDERSON S, INGELFINGER JR, HIRSCH AT, BOUYOUNES B, BRENNER BM: Renin-angiotensin system during evolution of nephrotic syndrome. (abstract) Clin Res 38:358A, 1990
56. PATEL R, ANSARI A: Serum angiotensin converting enzyme activity in patients with chronic renal failure on long term hemodialysis. Clin Chim Acta 92:491-495, 1979
57. WOLF G, THAISS F, SCHERBERICH SE: Glomerular angiotensinase A in the rat: Increase of enzyme activity following renal ablation. Kidney Int 38:862-868, 1990
58. KIM S, INAO H, NAKAMURA N, IKEMOTO F, YAMAMOTO K: Fate of circulating renin in rats. Am J Physiol 252:E136-E146, 1987
59. WARREN DJ, FERRIS TF: Renin secretion in renal hypertension. Lancet 1:159-163, 1970
60. CORREA-ROTTER R, HOSTETTER TH, MANIVEL JC, ROSENBERG ME: Renin expression in renal ablation. Hypertension 20:483-490, 1992
61. PUPILLI C, CHEVALIER RL, CAREY RM, GOMEZ A: Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263:F731-F738, 1992
62. TAUGNER R, HACKENTHAL E, HELMCHEN U, GANTEN D, KUGLER P, MARIN-GREZ M, NOBILING R, UNGER T, LOCKWALD I, KEILBACH R: The intrarenal renin-angiotensin system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins of mouse and rat. Klin Wockenschr 60:1218-1222, 1982
63. GOMEZ RA, CHEVALIER RL, STURGILL BC: Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 254:F900-F906, 1988
64. GOMEZ RA, LYNCH KR, CHEVALIER RL, WILFONG N, EVERETT AD, CAREY RM, PEACH MJ: Renin and angiotensinogen gene expression in the maturing rat kidney. Am J Physiol 254:F582-F587, 1988
65. GOMEZ RA, CHEVALIER RL, EVERETT AD, PEACH MJ, CAREY RM: Renin gene expression during salt depletion. (abstract) Kidney Int 35:300, 1989
66. DUNIHUE FW, BOZDOSSER NG: Observations on the similarity of mesangial to juxta-glomerular cells. Lab Invest 12:1228-1240, 1963
67. CHANSEL D, DUSSAULE JL, ARDAILLOU N, ARDAILLOU R: Identification and regulation of renin in human cultured mesangial cells. Am J Physiol 252:F32-F38, 1987
68. BLANTZ RL, KONNER KS, TUCKER BJ: Angiotensin II effect upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57:419-434, 1976
69. MEYER T, RENNKE HG: Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol 254:F856-F862, 1988
70. LOOMIS D, JETT-JACKSON CE: Plastic studies in abnormal renal architecture VI. An investigation of the circulation of infarcts in the kidney. Arch Pathol 33:735-769, 1942
71. CAMILLIERI JP, PHAT VN, BARIETY J, CORVAL P, MENARD J: Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem 28:1343-1346, 1980
72. MITCHEL KD, NAVAR LG: Superficial nephron responses to peritubular capillary infusions of angiotensin I and II. Am J Physiol 21:F818-F824, 1987
73. YOSHIDA Y, FOGO A, SHIRAGA H, GLICK AD, ICHIKAWA I: Serial-micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int 33:855-867, 1988
74. FARAGGIANA T, VENKATASESHAN VS, INAGAMI T, CHURG J: Immunohistochemical localization of renin in end-stage kidneys. Am J Kid Dis 12:194-199, 1988
75. LINDOP GBM, LEVER AF: Anatomy of the renin-angiotensin system in the normal and pathological kidney. Histopathology 10:335-362, 1986
76. GRAHAM PC, LINDOP GBM: The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int 33:1084-1090, 1988
77. TORRES VE, DONOVAN KA, SCICLI G, HOLLEY KE, THIBODEAU SN, CARRETERO OA, INAGAMI T, MCATEER JA, JOHNSON CM: Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int 42:364-373, 1992
78. GRAHAM PC, STEWART HVA, DOWNIE I, LINDOP GBM: The distribution of renin containing cells in kidneys with renal artery stenosis - An immunocytochemical study. Histopathology 16: 347-355, 1990
79. PEH SC, LINDOP GBM: Chronic pyelonephritis: The significance of renal renin and the vascular changes in the human kidney. J Pathol 163:343-349, 1991
80. GRAHAM PC, LINDOP GBM: The renin secreting cell in polyarteritis - an immunocytochemical study. Histopathology 16:339-345, 1990
81. AMAT P, CAMILLERI JP, PHAT VN, BARIETY J, CORVOL P, MENARD J: Renin localization in segmentai renal hypoplasia. Virchows Arch Pathol Anal 390:193-204, 1981
82. CHRISTENSEN JA, BOHLE A, MIKELER E, TAUGNER R: Renin-positive granulated Goormahtigh cells. Immunohistochemical and electron-microscopic studies on biopsies from patients with pseudo-Bartter's syndrome. Cell Tissue Res 255:149-153, 1989
83. STAHL RAK, KUDELA S, PARAVICINI M, SCHOLLMEYER B: Prostaglandin and thromboxane formation in glomeruli from rats with reduced renal mass. Nephron 42:252, 1986
84. NATH KA, CHMIELEWSKI DH, HOSTETTER TH: Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons. Am J Physiol 21:F829-F837, 1987
85. 2 into the renal artery of anesthesized dogs. Prostaglandins 15:81-88, 1978
86. ITO S, CARRETERO OA, ABE K, BEIERWALTES WH, YOSHINAGA K: Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int 35:1138-1144, 1989
87. DANIELS BS, HOSTETTER TH: Adverse effects of growth in the glomerular circulation. Am J Physiol 258:F1409-F1416, 1990
88. CAMPBELL-BOSWELL M, ROBERTSON AL JR: Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 35:265-276, 1981
89. SIMONIAN MH, GILL GN: Regulation of deoxyribonucleic acid synthesis in bovine adrenocortical cells in culture. Endocrinology 104:588-595, 1979
90. 1] angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258:H806-H813, 1990
91. WOLF G, NEILSON EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259:F768-F777, 1990
92. NORMAN J, BADIE-DEZFOOLY B, NORD EP, KURTZ I, SCHLOSSER J, CHAUDHARI A, FINE LG: EGF-induced mitogenesis in proximal tubular cells: Potentiation by angiotensin II. Am J Physiol 253:F299-F309, 1987
93. RAY PE, AGUILERA G, KOPP JB, HORIKOSHI S, KLOTMAN PE: Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int 40:764-771, 1991
94. HOMMA T, HOOVER RL, ICHIKAWA I, HARRIS RC: Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell. (abstract) Clin Res 38:358A, 1990
95. SINGHAL PC, FRANKI N, HAYS RM: Angiotensin II and norepinephrine induces actin synthesis in cultured mesangial cells. (abstract) Clin Res 38:401A, 1990
96. ROSENBERG ME, HOSTETTER TH: The effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. Kidney Int 43:601-609, 1993
97. CHOBANIAN MC, JULIN CM: Angiotensin II stimulates ammoniagenesis in canine renal proximal tubule segments. Am J Physiol 260:F19-F26, 1991
98. 4Cl. J Clin Invest 84:1767-1779, 1989
99. NATH KA, HOSTETTER MK, HOSTETTER TH: Pathophysiology of chronic tubulointerstitial disease in rats: Interaction of dietary acid load, ammonia, and complement component C3. J Clin Invest 76:667-675, 1985
100. KEANE WF, RAIJ L: Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Lab Invest 52:599-604, 1985
101. HALL JE: Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc 45:1431-1437, 1986
102. NATH KA, CROATT AJ, HOSTETTER TH: Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 258: F1354-F1362, 1990